Treatment of donor cells with l-leucyl-l-leucine methyl ester prevents induction of graft-vs-host-like reaction in [lprlpr → +/+] chimera
-
Add time:09/03/2019 Source:sciencedirect.com
Irradiated C57BL/6 (B6) mice which had received spleen cells from autoimmune-prone C57BL/6J-lpr/lpr (B6-lpr) mice underwent a graft-versus-host (GvH)-like reaction early after the spleen cell transfer, although both strains have the same background genes, including MHC and Mls gene, but differ only in a lpr gene. We analyzed the changes in this GvH-like reaction when the donor spleen cells had been treated with l-leucyl-l-leucine methyl ester, which has been reported to have an inhibitory effect on the early GvH reaction in allogeneic or semiallogeneic chimeras. The treatment of donor spleen cells completely abrogated the induction of the early phase of the GvH-like reation in [B6-lpr → B6] chimeras. The results suggest that the GvH-like reaction in these chimeras is caused by a mechanism(s) similar to that operating in allogeneic or semiallogeneic chimeras.
We also recommend Trading Suppliers and Manufacturers of leucyl-leucine-methyl ester (cas 13022-42-9). Pls Click Website Link as below: cas 13022-42-9 suppliers
Prev:Regular ArticleSynthesis and Cytotoxic Studies of 5-O-(β–Glucopyranosyl)-2-nitrobenzyl Cagedl-Leucyl-l-Leucine Methyl Ester with Increased Solubility in PBS Containing 1% DMSO☆☆☆
Next:Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical ResearchAntiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease09/05/2019
- Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk09/04/2019
- Regular ArticleSynthesis and Cytotoxic Studies of 5-O-(β–Glucopyranosyl)-2-nitrobenzyl Cagedl-Leucyl-l-Leucine Methyl Ester with Increased Solubility in PBS Containing 1% DMSO☆☆☆09/02/2019
- Original ArticleEffects of the Immunosuppressive Dipeptide L-Leucyl-L-Leucine O-Methyl Ester on Epidermal Langerhans Cells09/01/2019
- Design, synthesis, photochemical properties and cytotoxic activities of water-Soluble caged l-Leucyl-l-leucine methyl esters that control apoptosis of immune cells08/31/2019
- Research paperEpstein-Barr virus-induced transformation of human B lymphocytes: the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations08/30/2019
- Regular ArticleSynthesis of Caged Compounds of L-Leucyl-L-Leucine Methyl Ester, an Apoptosis Inducer, and Their Cytotoxic Activity08/29/2019
- Regular ArticleCell-Type Specificity of l-Leucyl l-Leucine Methyl Ester08/28/2019


